🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

I often take care of people after suicide attempts. When they explain why they tried to die, a large proportion say they could no longer see “the point” in life. “There’s no meaning for me, no reason to live.” Most clinicians push against this idea to dissuade people from it. 1/

Harm reduction is an essential strategy to keep people who use drugs alive until they can get into recovery. I am issuing a standing order for pharmacies across the State to carry naloxone and dispense it without a prescription beginning Monday. More here: health.ny.gov/diseases/aids/…

Happy to (finally) share this piece - the culmination of a little hard work and a lot of mentorship.🙏 journals.asm.org/doi/10.1128/aa… Will Eward, Nick Turner, Alexander Lazarides, Daniel Evans, Nicole Levine, Duke IM Residency

How about leave the medicine to the doctors and the decisions to the women.

Privatized, medicalized public health is not in fact public health at all.

We actually have things we can do to help people with alcohol use disorder - help them with cravings and cut down/cease alcohol use. considering ~4% of ED visits may be related to alcohol, this is a BIG deal Listen: foamcast.libsyn.com/naltrexone-for… Read: foamcast.org/2023/09/06/nal…

Remarkable RCT from Norway demonstrating that starting HCV treatment in the hospital with newly diagnosed HCV among PWIDs is superior to deferring therapy to outpatient care in achieving HCV cure. Results argue for broader use. Håvard Midgard SELIHEP doi.org/10.1093/cid/ci…

🔖Excited to share a piece on a topic near and dear to my heart - how we manage AUD in patients with alcohol-associated liver disease. Shoutout to Sasha Deutsch-Link, MD MSCR for her mentorship and expertise in this field! sciencedirect.com/science/articl… #livertwitter Duke IM Residency

Safety of naltrexone for AUD in cirrhosis - No patients were classified as possible, probable, or highly probable DILI. No deaths or new decompensations were attributed to naltrexone Raj VuppaLanchi Lauren Nephew MD, MSCE Naga Chalasani Ramon Bataller VCU Stravitz-Sanyal Institute for Liver Disease pubmed.ncbi.nlm.nih.gov/38961852/

Alcohol-related liver disease is a case study in health inequality: 🏴󠁧󠁢󠁥󠁮󠁧󠁿 ALD incidence rate increase with increasing deprivation The most deprived neighborhoods experienced the highest absolute increase in incidence from 2001-18 journals.lww.com/ajg/fulltext/2… @HepatoEpi #LiverTwitter

This large study has a positive result that needs to be highlighted: CONSULTING AN ADDICTION SPECIALIST DECREASES MORTALITY IN ALCOHOL-ASSOCIATED HEPATITIS. We must do it. t.ly/yugVi